When your in-house efforts need an added boost, Advocacy Options steps up
Our mission is to aid executives of patient advocacy organizations in assuring their patient constituency have access to their health care through research funding, patient centric laws and regulations. Our executive and advocacy services assist patient advocacy organizations to protect patients, especially those with rare and/or chronic diseases, from government and private insurance health care practices that place economic and discriminatory policy barriers to health care including but not limited to high deductibles and co-insurance which hurt peoples’ ability to access the health care they need.
Advocacy Options expertise comprises:
- Public Policy advocacy
- Health Care policy specialty
- Policy Analysis
- Strategic Planning and Vision
- Turning Vision into Reality
- Non-Profit Executive Leadership
- Government Policy and Operations
- Grassroots and Grasstops Advocacy
- Community Outreach
- Solution Development
- Stakeholder Relations
- Finance and Budget
- Core Values and Dedication
- Grant Development
- Strategic Communications
- Coalition Creation and Leadership
Contact Advocacy Options’ Principal Lawrence (Larry) LaMotte at llamotte6394@gmail.com or 410-458-8336
One stop for your strategic healthcare advocacy plans
| Develop or analyze health policies. | Seek public funds for research for specific diseases. | Assist organizations with legislation, regulatory comments, Patient Focused Drug Development (PFDD) meetings and communications. |
| Develop public policy strategies for health care. | Organize, coordinate or lead stakeholder coalitions to leverage advocacy efforts. | Develop a grassroots lobbying program. |
Principal Consultant Lawrence A. LaMotte
For over 30 years, Larry LaMotte has worked with opinion leaders, lobbyists, politicians, and healthcare leaders to shape health care policy and advocate for patients’ increased access to care.
Clients value his thoughtful listening and consideration of varied tactical approaches that client organizations can actually achieve. Clients value Larry’s attention to project costs. He’s a business man himself and understands the importance of resource allocation in meeting goals.
Some of his accomplishments include leading advocacy efforts to pass the Medicare IVIG Demonstration Act into law. He also lead the efforts to have all 50 states and territories screen all newborns for Severe Combined Immunodeficiency Disease (SCID or “bubble boy disease”). He was also instrumental in the changes in policy reducing the HHS and FDA restrictions as to who can donate blood and plasma while keeping the blood and plasma supply safe.
Larry has shared his expertise as a featured speaker at numerous conferences including NORD Annual Summit, World Biosimilars Conferences in the United States and Europe, Biosimilars Summits, Financial Times US Healthcare & Life Sciences Summit, BIO International Convention, Alliance for Patient Access National Policy and Advocacy Summit on Biologics and Biosimilars and more.
Solid Experience · Real Leadership · Effective Results
|
|
|
|
|
|
